Universal Corp. Posts Strong Q2 Earnings, Net Income Jumps 31.7%
Ticker: UVV · Form: 10-Q · Filed: Nov 5, 2025 · CIK: 102037
| Field | Detail |
|---|---|
| Company | Universal Corp /Va/ (UVV) |
| Form Type | 10-Q |
| Filed Date | Nov 5, 2025 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $21 million |
| Sentiment | bullish |
Sentiment: bullish
Topics: Agri-products, Tobacco, Earnings Growth, Cash Flow, International Operations, VAT Assessment, Inventory Management
Related Tickers: UVV, MO, PM, BTI
TL;DR
**UVV is crushing it with big earnings growth and a major tax win, making it a solid buy despite cash flow dips from inventory builds.**
AI Summary
Universal Corporation (UVV) reported a strong financial performance for the three and six months ended September 30, 2025. For the three-month period, sales and other operating revenues increased by 6.1% to $754.18 million from $710.76 million in the prior year. Net income attributable to Universal Corporation surged by 31.7% to $34.17 million, up from $25.94 million. Diluted earnings per share also rose significantly to $1.36 from $1.03. For the six-month period, sales and other operating revenues grew by 3.1% to $1.35 billion from $1.31 billion. Net income attributable to Universal Corporation saw a substantial increase of 63.6% to $42.67 million, compared to $26.07 million in the same period last year, with diluted EPS reaching $1.70 from $1.04. The company incurred $1.12 million in restructuring and impairment costs for the six months ended September 30, 2025, primarily related to consolidating European sheet tobacco operations, a decrease from $10.57 million in the prior year. A favorable ruling in July 2025 by the Brazilian National Treasury Attorney's office resolved a significant VAT assessment in Brazil, declaring the Parana assessment without merit. Cash and cash equivalents decreased to $88.65 million at September 30, 2025, from $260.12 million at March 31, 2025, largely due to increased inventories of $367.01 million for the six-month period.
Why It Matters
Universal Corporation's robust earnings growth, with net income attributable to UVV up 31.7% for the quarter and 63.6% for the six months, signals strong operational execution and potentially improved market conditions for its agri-products. The favorable resolution of the Brazilian VAT assessment removes a significant contingent liability, enhancing financial stability and reducing legal overhang, which is positive for investor confidence. Increased inventory levels, while impacting cash flow, could indicate anticipation of higher future demand or strategic purchasing, positioning UVV competitively against rivals in the leaf tobacco and plant-based ingredients sectors. This performance could attract investors seeking stable dividend payers with growth potential in the agricultural commodities space.
Risk Assessment
Risk Level: medium — The company's cash and cash equivalents decreased significantly by $171.46 million for the six months ended September 30, 2025, primarily due to a $367.01 million increase in inventories, indicating substantial cash outflow for working capital. While the Brazilian VAT assessment was favorably resolved, the company still faces inherent risks from the seasonal nature of its business and potential volatility in agricultural commodity markets, as noted in Note 1.
Analyst Insight
Investors should consider UVV's strong earnings and the positive resolution of the Brazilian tax issue as indicators of operational strength. However, monitor the significant increase in inventories and the associated cash outflow, as this could impact short-term liquidity. A deeper dive into the inventory composition and future demand projections would be prudent.
Financial Highlights
- revenue
- $1.35B
- operating Margin
- 7.53%
- total Assets
- $2.68B
- net Income
- $42.67M
- eps
- $1.70
- gross Margin
- 19.31%
- cash Position
- $88.65M
- revenue Growth
- +3.1%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Tobacco | $1,138,630,000 | +7.7% |
| Other Plant-Based Ingredients | $222,505,000 | +17.3% |
Key Numbers
- $754.18M — Sales and other operating revenues (Increased by 6.1% for the three months ended September 30, 2025, compared to $710.76 million in 2024.)
- $34.17M — Net income attributable to Universal Corporation (Increased by 31.7% for the three months ended September 30, 2025, from $25.94 million in 2024.)
- $1.36 — Diluted EPS (Increased from $1.03 for the three months ended September 30, 2024, to $1.36 in 2025.)
- $1.35B — Sales and other operating revenues (Increased by 3.1% for the six months ended September 30, 2025, compared to $1.31 billion in 2024.)
- $42.67M — Net income attributable to Universal Corporation (Increased by 63.6% for the six months ended September 30, 2025, from $26.07 million in 2024.)
- $1.70 — Diluted EPS (Increased from $1.04 for the six months ended September 30, 2024, to $1.70 in 2025.)
- $1.12M — Restructuring and impairment costs (Decreased significantly from $10.57 million in the six months ended September 30, 2024, to $1.12 million in 2025.)
- $88.65M — Cash and cash equivalents (Decreased from $260.12 million at March 31, 2025, to $88.65 million at September 30, 2025.)
- $367.01M — Inventories increase (Major factor in cash outflow for the six months ended September 30, 2025.)
- 24,921,155 — Common shares outstanding (As of November 3, 2025.)
Key Players & Entities
- UNIVERSAL CORPORATION (company) — registrant
- UVV (company) — ticker symbol
- Brazilian National Treasury Attorney's office (regulator) — issued a favorable ruling
- $754,177 (dollar_amount) — sales and other operating revenues for three months ended September 30, 2025
- $710,762 (dollar_amount) — sales and other operating revenues for three months ended September 30, 2024
- $34,169 (dollar_amount) — net income attributable to Universal Corporation for three months ended September 30, 2025
- $25,940 (dollar_amount) — net income attributable to Universal Corporation for three months ended September 30, 2024
- $1.36 (dollar_amount) — diluted earnings per share for three months ended September 30, 2025
- $1.03 (dollar_amount) — diluted earnings per share for three months ended September 30, 2024
- $1.12 million (dollar_amount) — restructuring and impairment costs for six months ended September 30, 2025
FAQ
What were Universal Corporation's sales and net income for the quarter ended September 30, 2025?
Universal Corporation reported sales and other operating revenues of $754.18 million for the three months ended September 30, 2025, an increase from $710.76 million in the prior year. Net income attributable to Universal Corporation for the quarter was $34.17 million, up significantly from $25.94 million in the same period of 2024.
How did Universal Corporation's earnings per share change for the six months ended September 30, 2025?
For the six months ended September 30, 2025, Universal Corporation's diluted earnings per share increased to $1.70, a notable rise from $1.04 reported for the six months ended September 30, 2024.
What was the impact of restructuring costs on Universal Corporation's financials?
Universal Corporation incurred $1.12 million in restructuring and impairment costs for the six months ended September 30, 2025, primarily due to consolidating European sheet tobacco operations. This is a substantial decrease from the $10.57 million in restructuring and impairment costs reported for the same period in 2024.
What was the outcome of the Value-Added Tax assessments in Brazil for Universal Corporation?
In July 2025, Universal Corporation received a final and indisputable favorable ruling from the Brazilian National Treasury Attorney's office regarding the Parana VAT assessment. This ruling declared the assessment without merit, requiring the state to withdraw and cancel all claims against the company's Brazilian operating subsidiary.
How did Universal Corporation's cash position change during the six months ended September 30, 2025?
Universal Corporation's cash and cash equivalents decreased by $171.46 million, from $260.12 million at the beginning of the year to $88.65 million at September 30, 2025. This decrease was largely driven by a $367.01 million increase in inventories.
What are Universal Corporation's primary revenue-generating categories?
Universal Corporation's primary revenue-generating categories include tobacco sales, which accounted for $1.08 billion for the six months ended September 30, 2025, and ingredient sales, which contributed $173.78 million during the same period. Processing revenue and other sales also contribute to total revenue.
What is Universal Corporation's strategic outlook regarding its operations?
Universal Corporation regularly reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes, as evidenced by the consolidation of its European sheet tobacco operations into its Netherlands facility.
What are the key risks Universal Corporation faces according to the 10-Q?
Key risks include the seasonal nature of the company's business, which means quarterly results may not be indicative of full-year performance. Additionally, the company provides advances to tobacco farmers, and there's a risk that individual farmers may not deliver sufficient volumes to fully repay these advances, as noted by the $13 million in valuation allowances at September 30, 2025.
What new accounting standards will Universal Corporation adopt in future years?
Universal Corporation is evaluating the impact of ASU 2023-09, 'Improvements to Income Tax Disclosures,' effective for fiscal years beginning after December 15, 2024, and ASU 2024-03, 'Disaggregation of Income Statement Expenses,' effective for fiscal years beginning after December 15, 2026.
How much did Universal Corporation declare in dividends per common share?
Universal Corporation declared dividends of $0.82 per common share for the three months ended September 30, 2025, and $1.64 per common share for the six months ended September 30, 2025.
Risk Factors
- Inventory Management [medium — operational]: Inventories increased by $332.3 million to $1.36 billion for the six months ended September 30, 2025. This significant increase, while potentially strategic, ties up substantial working capital and could be exposed to obsolescence or market price fluctuations.
- Future Tax Disclosure Requirements [low — regulatory]: The company is evaluating the impact of ASU 2023-09, effective for fiscal years beginning after December 15, 2024, which requires additional disclosures reconciling income tax rates and disaggregating taxes paid. Compliance with new disclosure mandates requires careful attention.
- European Sheet Tobacco Consolidation [medium — operational]: The company incurred $1.12 million in restructuring and impairment costs for consolidating European sheet tobacco operations in the six months ended September 30, 2025. While down from $10.57 million in the prior year, ongoing integration risks and potential future costs remain.
- VAT Assessment Resolution [low — legal]: A favorable ruling in July 2025 by the Brazilian National Treasury Attorney's office resolved a significant VAT assessment, declaring the Parana assessment without merit. This removes a material legal contingency.
Industry Context
Universal Corporation operates as a global business-to-business agri-products supplier, primarily as the leading global leaf tobacco supplier and a provider of plant-based ingredients for food and beverage markets. The industry is characterized by long-term supply contracts, global sourcing, and increasing demand for sustainable and plant-based alternatives. Competition involves managing complex supply chains and meeting diverse customer specifications.
Regulatory Implications
The company faces ongoing regulatory scrutiny related to international tax laws, as evidenced by the resolved Brazilian VAT assessment. Future compliance with evolving tax disclosure standards (ASU 2023-09) will require careful management. Operational restructuring also necessitates adherence to labor and environmental regulations in affected regions.
What Investors Should Do
- Monitor inventory levels and turnover ratios.
- Analyze the impact of restructuring costs on margins.
- Evaluate the growth drivers for plant-based ingredients.
Key Dates
- 2025-09-30: End of Q2 Fiscal Year 2025 — Reporting period for the 10-Q, showing increased revenues and net income compared to the prior year.
- 2025-07-01: Favorable Brazilian VAT Ruling — Resolved a significant tax assessment, removing a material legal risk and potential financial impact.
- 2025-03-31: End of Fiscal Year 2025 — Prior period balance sheet date, showing a higher cash position ($260.12M) than at September 30, 2025.
Glossary
- Noncontrolling interests
- The portion of equity in a subsidiary that is not attributable to the parent company. It represents the ownership stake of outside shareholders. (The net income and comprehensive income attributable to Universal Corporation are reported after deducting amounts attributable to noncontrolling interests, impacting the parent company's reported profitability.)
- Operating lease right-of-use assets
- Assets recognized under accounting standards for leases, representing the right to use an underlying asset for the lease term. (These assets are part of the company's long-term asset base and reflect obligations related to leased properties or equipment.)
- Equity in pretax earnings (loss) of unconsolidated affiliates
- The company's share of the profits or losses of companies in which it has a significant influence but does not control. (This line item reflects the financial performance of joint ventures or associated companies, impacting overall income before taxes.)
- Restructuring and impairment costs
- Expenses incurred due to significant reorganizations, closures, or write-downs of assets. (These costs, particularly those related to consolidating European sheet tobacco operations, indicate strategic adjustments and their associated financial impact.)
Year-Over-Year Comparison
For the six months ended September 30, 2025, Universal Corporation demonstrated robust growth compared to the prior year. Revenue increased by 3.1% to $1.35 billion, and net income attributable to the corporation surged by 63.6% to $42.67 million, with diluted EPS rising to $1.70 from $1.04. A significant reduction in restructuring and impairment costs, from $10.57 million to $1.12 million, positively impacted profitability. However, cash and cash equivalents saw a substantial decrease from $260.12 million to $88.65 million, primarily due to a large increase in inventories.
Filing Stats: 4,438 words · 18 min read · ~15 pages · Grade level 16.4 · Accepted 2025-11-05 16:19:22
Key Financial Figures
- $21 million — $ 22 million at September 30, 2025 and $21 million at September 30, 2024 and March 31, 202
Filing Documents
- uvv-20250930.htm (10-Q) — 1418KB
- uvv-exhibit311x20250930.htm (EX-31.1) — 10KB
- uvv-exhibit312x20250930.htm (EX-31.2) — 10KB
- uvv-exhibit321x20250930.htm (EX-32.1) — 6KB
- uvv-exhibit322x20250930.htm (EX-32.2) — 6KB
- 0001628280-25-049596.txt ( ) — 8355KB
- uvv-20250930.xsd (EX-101.SCH) — 36KB
- uvv-20250930_cal.xml (EX-101.CAL) — 70KB
- uvv-20250930_def.xml (EX-101.DEF) — 185KB
- uvv-20250930_lab.xml (EX-101.LAB) — 569KB
- uvv-20250930_pre.xml (EX-101.PRE) — 387KB
- uvv-20250930_htm.xml (XML) — 1754KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION 1. Financial Statements 3 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 26 3. Quantitative and Qualitative Disclosures About Market Risk 34 4. Controls and Procedures 34
- OTHER INFORMATION
PART II - OTHER INFORMATION 1. Legal Proceedings 36 1A.
Risk Factors
Risk Factors 36 2. Unregistered Sales of Equity Securities and Use of Proceeds 36 5. Other Information 36 6. Exhibits 37
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS UNIVERSAL CORPORATION CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (in thousands, except share and per share data) Three Months Ended September 30, Six Months Ended September 30, 2025 2024 2025 2024 (Unaudited) (Unaudited) Sales and other operating revenues $ 754,177 $ 710,762 $ 1,347,939 $ 1,307,812 Costs and expenses Cost of goods sold 614,347 567,617 1,093,982 1,068,746 Selling, general and administrative expenses 72,181 63,836 151,373 142,532 Restructuring and impairment costs — 10,573 1,122 10,573 Operating income 67,649 68,736 101,462 85,961 Equity in pretax earnings (loss) of unconsolidated affiliates ( 2,561 ) ( 642 ) ( 126 ) ( 502 ) Other non-operating income (expense) 582 461 1,168 925 Interest income 778 295 1,425 1,103 Interest expense 20,438 21,273 38,215 42,007 Income (loss) before income taxes and other items 46,010 47,577 65,714 45,480 Income taxes 11,207 13,608 16,544 14,335 Net income (loss) 34,803 33,969 49,170 31,145 Less: net loss (income) attributable to noncontrolling interests in subsidiaries ( 634 ) ( 8,029 ) ( 6,504 ) ( 5,075 ) Net income (loss) attributable to Universal Corporation $ 34,169 $ 25,940 $ 42,666 $ 26,070 Earnings per share: Basic $ 1.36 $ 1.04 $ 1.71 $ 1.05 Diluted $ 1.36 $ 1.03 $ 1.70 $ 1.04 Weighted average common shares outstanding: Basic 25,035,110 24,946,632 25,017,765 24,911,681 Diluted 25,178,546 25,135,973 25,155,627 25,101,295 Total comprehensive income (loss), net of income taxes $ 34,654 $ 33,531 $ 57,756 $ 25,181 Less: comprehensive (income) loss attributable to noncontrolling interests ( 356 ) ( 8,026 ) ( 6,249 ) ( 4,682 ) Comprehensive income (loss) attributable to Universal Corporation $ 34,298 $ 25,505 $ 51,507 $ 20,499 Dividends declared per common share $ 0.82 $ 0.81 $ 1.64 $ 1.62 See accompanying notes. 3 UNIVERSAL CORPORATION CONSOLIDATED BALANCE SHEETS (in thousands of dollars, except share data) September 30, S
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 1. BASIS OF PRESENTATION Universal Corporation, which together with its subsidiaries is referred to herein as "Universal" or the "Company," is a global business-to-business agri-products supplier to consumer product manufacturers. The Company is the leading global leaf tobacco supplier and provides high-quality plant-based ingredients to food and beverage end markets. Because of the seasonal nature of the Company's business, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. All adjustments necessary to state fairly the results for the period have been included and were of a normal recurring nature. This Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2025. Accounting Pronouncements to be Adopted in Future Years In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2023-09, "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures" ("ASU 2023-09"). ASU 2023-09 requires additional disclosures reconciling the rates of different categories of income tax (i.e. federal, state, foreign, etc.) and a disaggregation of taxes paid and refunded. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and for interim periods in fiscal years beginning after December 15, 2025, although early adoption is permitted. The Company is currently evaluating the impact of adopting this standard on its income tax disclosures. In November 2024, the FASB issued Accounting Standards Update No. 2024-03, "Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40) - Disaggregation of Income Statement Expenses" ("ASU 2024-03"). ASU 2024-03 requires additional disclosures about